COVID Often Joined by Heart Disease, Diabetes
WEDNESDAY, July 20, 2022 (HealthDay News) — In a mix of bad and good news, a new large study confirms that COVID can raise the risks of new-onset heart trouble and diabetes — though those threats typically wane again after a few months.The study, of…
Learn MoreFewer Americans Are Dying of Heart Disease Than a Decade Ago
TUESDAY, July 19, 2022 (HealthDay News) — Deaths from heart-related causes have dropped over the past 20 years, though differences persist by race and ethnicity as well as where people live and their access to care.The U.S. National Institutes of Hea…
Learn MoreWho’ll Get Long COVID? Just a Look at a Patient Gives Clues
TUESDAY, July 19, 2022 (HealthDay News) — Sometimes just looking at a person can give clues to their likelihood of developing long COVID after a bout with the virus.For example, obese people are five times more likely to suffer long COVID symptoms th…
Learn MoreUn método ‘escalonado’ quizá sea mejor para tratar a la enfermedad ocular diabética
VIERNES, 15 de julio de 2022 (HealthDay News) — Un medicamento de marca genérica para el edema macular diabético quizá resulte igual de efectivo en el tratamiento temprano que una alternativa más cara, lo que ahorraría potencialmente miles de dólares…
Learn MoreEffect of Keto and Mediterranean Diets on Glucose Control Compared
MONDAY, July 18, 2022 (HealthDay News) — While the Keto and Mediterranean diets both can help people manage diabetes, the Mediterranean diet appears easier to maintain, according to a study recently published in the American Journal of Clinical Nutri…
Learn MoreDiabetic Macular Edema Outcomes Compared for Aflibercept, Bevacizumab
FRIDAY, July 15, 2022 (HealthDay News) — For treatment of diabetic macular edema involving the center of the macular, two-year outcomes are similar for those treated with aflibercept monotherapy and with bevacizumab first then a switch to aflibercept…
Learn MoreFactory-Calibrated CGM Seems Accurate for Hemodialysis Patients
FRIDAY, July 15, 2022 (HealthDay News) — For individuals on hemodialysis, a factory-calibrated continuous glucose monitor (CGM) appears to be reasonably accurate, according to a study published in the July issue of Diabetes Care.Orianne Villard, Ph.D…
Learn More‘Stepped’ Approach to Treating Diabetic Eye Disease May Be Best
FRIDAY, July 15, 2022 (HealthDay News) — An off-brand medication for diabetic macular edema might prove just as effective in early treatment as its more expensive alternative, potentially saving patients thousands of dollars, new research suggests.Th…
Learn MoreLos pagos de discapacidad pueden ayudar a mantener a los veteranos con diabetes fuera del hospital
VIERNES, 8 de julio de 2022 (HealthDay News) — Un mayor número de pagos de discapacidad condujo a menos hospitalizaciones entre los veteranos de Vietnam con diabetes, según un informe reciente.La investigación observó a 14,000 veteranos de Vietnam qu…
Learn MoreCalifornia producirá su propia insulina para reducir precios
VIERNES, 8 de julio de 2022 (HealthDay News) — El gobernador de California, Gavin Newsom, anunció el martes que el estado gastará 100 millones de dólares para producir su propia insulina.La innovadora iniciativa llega tras años de precios astronómico…
Learn More